John Flack

Jan 8, 2025 | hcplive.com | Manesh R. Patel |Payal Kohli |John Flack |C. Michael Gibson

OpinionVideoJanuary 8, 2025Author(s):, Difficult-to-treat hypertension involves uncontrolled blood pressure despite using three or more antihypertensive medications, including a diuretic. It is distinct from resistant hypertension, which is more common and may not include a diuretic in treatment. This condition affects a smaller subset of patients with high blood pressure and requires a comprehensive management approach.

Jan 8, 2025 | consultantlive.com | Manesh R. Patel |Payal Kohli |John Flack |C. Michael Gibson

Advancing Hypertension Management: Unmet Needs, Endothelial Dysfunction, and CKD Therapies - Episode 11Published on: , , , Panelists discuss how chronic kidney disease (CKD) and uncontrolled hypertension create a damaging cycle, in which hypertension accelerates kidney damage while declining kidney function makes blood pressure harder to control. Patient No. 2 has stage 3 CKD and uncontrolled hypertension.

Dec 11, 2024 | hcplive.com | Manesh R. Patel |Payal Kohli |John Flack |C. Michael Gibson

OpinionVideoDecember 11, 2024Author(s):, Difficult-to-treat hypertension involves uncontrolled blood pressure despite using three or more antihypertensive medications, including a diuretic. It is distinct from resistant hypertension, which is more common and may not include a diuretic in treatment. This condition affects a smaller subset of patients with high blood pressure and requires a comprehensive management approach.

Dec 11, 2024 | hcplive.com | Manesh R. Patel |Payal Kohli |John Flack |C. Michael Gibson

OpinionVideoDecember 11, 2024Author(s):, Antihypertensive drug classes include diuretics, beta-blockers, ACE inhibitors, ARBs, calcium channel blockers, and alpha-blockers, each with distinct mechanisms of action targeting blood pressure regulation. Diuretics reduce blood volume, beta-blockers decrease heart rate, ACE inhibitors and ARBs inhibit the renin-angiotensin-aldosterone system, and calcium channel blockers relax blood vessels.

Dec 4, 2024 | hcplive.com | Manesh R. Patel |Payal Kohli |John Flack |C. Michael Gibson

OpinionVideoDecember 4, 2024Author(s):, Traditional antihypertensive drugs often result in variable patient responses and side effects, complicating treatment efficacy and patient adherence. Lifelong administration of these medications can lead to compliance issues, impacting long-term management of hypertension. Current treatments primarily manage symptoms rather than addressing the underlying pathophysiology of hypertension.